SENYEI ANDREW E 4
4 · COMPLETE GENOMICS INC · Filed Nov 16, 2010
Insider Transaction Report
Form 4
SENYEI ANDREW E
Director10% Owner
Transactions
- Conversion
Common Stock, par value $0.001
2010-11-16+259,458→ 436,195 total(indirect: See Footnote) - Exercise of In-Money
Common Stock, par value $0.001
2010-11-16$7.56/sh+138,794$1,049,283→ 574,989 total(indirect: See Footnote) - Exercise of In-Money
Common Stock, par value $0.001
2010-11-16$7.56/sh+17,261$130,493→ 569,117 total(indirect: See Footnote) - Tax Payment
Common Stock, par value $0.001
2010-11-16$9.00/sh−14,500$130,500→ 554,617 total(indirect: See Footnote) - Exercise of In-Money
Warrant to Purchase Series D Preferred Stock
2010-11-16−8,378→ 0 total(indirect: See Footnote)Exercise: $7.56Exp: 2014-06-12→ Common Stock (8,378 underlying) - Conversion
Common Stock, par value $0.001
2010-11-16+27,049→ 101,043 total(indirect: See Footnote) - Conversion
Common Stock, par value $0.001
2010-11-16+176,737→ 176,737 total(indirect: See Footnote) - Tax Payment
Common Stock, par value $0.001
2010-11-16$9.00/sh−23,133$208,197→ 551,856 total(indirect: See Footnote) - Tax Payment
Common Stock, par value $0.001
2010-11-16$9.00/sh−7,038$63,342→ 555,957 total(indirect: See Footnote) - Purchase
Common Stock, par value $0.001
2010-11-16$9.00/sh+111,111$999,999→ 667,068 total(indirect: See Footnote) - Exercise of In-Money
Warrant to Purchase Series D Preferred Stock
2010-11-16−17,261→ 0 total(indirect: See Footnote)Exercise: $7.56Exp: 2014-04-06→ Common Stock (17,261 underlying) - Conversion
Common Stock, par value $0.001
2010-11-16+66,138→ 66,138 total(indirect: See Footnote) - Exercise of In-Money
Common Stock, par value $0.001
2010-11-16$7.56/sh+8,378$63,338→ 562,995 total(indirect: See Footnote) - Exercise of In-Money
Warrant to Purchase Series D Preferred Stock
2010-11-16−2,958→ 0 total(indirect: See Footnote)Exercise: $7.56Exp: 2014-06-12→ Common Stock (2,958 underlying) - Exercise of In-Money
Warrant to Purchase Series D Preferred Stock
2010-11-16−1,096→ 0 total(indirect: See Footnote)Exercise: $7.56Exp: 2014-08-05→ Common Stock (1,096 underlying)
Footnotes (6)
- [F10]The warrant is immediately exercisable.
- [F2]The shares are owned by Enterprise Partners VI, LP ("Enterprise VI"). Enterprise Management Partners VI, LLC ("Enterprise VI LLC") serves as the general partner of Enterprise VI. Andrew E. Senyei, M.D. is a managing director of Enterprise VI LLC and shares voting and investment power over the shares held by Enterprise VI. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his proportionate pecuniary interest therein.
- [F5]Each share of Series D and Series E Preferred Stock was automatically converted into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering.
- [F6]The shares are owned by Enterprise Partners Management, LLC ("Enterprise LLC"). Andrew E. Senyei, M.D. is a managing director of Enterprise LLC and shares voting and investment power over the shares held by Enterprise LLC. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his proportionate pecuniary interest therein.
- [F7]The shares are owned by Enterprise Partners V, LP ("Enterprise V"). Enterprise Management Partners V, LLC ("Enterprise V LLC") serves as the general partner of Enterprise V. Andrew E. Senyei, M.D. is a managing director of Enterprise V LLC and shares voting and investment power over the shares held by Enterprise V. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his proportionate pecuniary interest therein.
- [F8]The securities are immediately convertible.